Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
revenue alongside Mounjaro, the company's diabetes treatment. Year to date, the stock is already up 57% as investors continue to pile money into the growth beast. But you may not want to buy the stock around its highs, if you feel you might have missed the boat on Eli Lilly. The good news is that there's a much smaller healthcare stock that can also give you some terrific growth prospects in the anti-obesity market: Zealand Pharma (OTC: ZLDP.F) . Here's why this might be an exciting stock to own. The company has a couple of promising assets Zealand Pharma is a Danish-based biotech company with a market cap of around $9.3 billion -- a small fraction of Eli Lilly's monstrous $820 billion valuation. But investors have been starting to take notice of this up-and-coming healthcare stock; its shares are up more than 135% this year. What has investors excited is not just one but two exciting treatments aimed at helping people lose weight. The stock recently got a boost after Zealand
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly's Donanemab Approval Heats Up Alzheimer's Disease Treatment Market | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal [Seeking Alpha]Seeking Alpha
- GordonMD® Global Investments Portfolio Company, Radionetics Oncology, Announced Strategic Agreement with Lilly [Yahoo! Finance]Yahoo! Finance
- GordonMD® Global Investments Portfolio Company, Radionetics Oncology, Announced Strategic Agreement with LillyBusiness Wire
- 3 No-Brainer Stocks to Buy in July [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 7/8/24 - Form 4
- 7/3/24 - Form 4
- 7/2/24 - Form 4
- LLY's page on the SEC website